SCHEMBL2487772

SCHEMBL2487772

CC(C)(C)OC(=O)N1CCc2c(cnc3[nH]nc(-c4ccccc4)c23)C1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.46
SKP1 P63208 2/20 0.46
SKP2 Q13309 2/20 0.46
UCHL1 P09936 2/20 0.46
MAPT P10636 2/20 0.44
MAPK1 P28482 1/20 0.43
USP30 Q70CQ3 2/20 0.43
PARP1 P09874 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
ESR2 Q92731 1/20 0.42
NR1H2 P55055 1/20 0.41
P2RX3 P56373 2/20 0.41
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
NAMPT P43490 1/20 0.41
SCN9A Q15858 1/20 0.41
KIT P10721 1/20 0.40
HPGDS O60760 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2487072 0.88 PARP1 (0.45) UCHL1MAPTMAPK1PARP1TNKS2
SCHEMBL2485087 0.88 NR1H2 (0.41) UCHL1MAPTUSP30PARP1TNKS2
SCHEMBL2486503 0.87 MKNK1 (0.41) UCHL1MAPTPARP1TNKS2PARP2
SCHEMBL2802667 0.85 NR1H2 (0.38) UCHL1MAPTUSP30PARP1TNKS2
SCHEMBL2484168 0.85 NAMPT (0.39) UCHL1MAPTUSP30PARP1TNKS2
SCHEMBL2487129 0.84 MAPT (0.46) MAPTMAPK1PARP1TNKS2PARP2
SCHEMBL2483733 0.81 NAMPT (0.58) NAMPT
SCHEMBL2512524 0.81 NPC1 (0.51) NAMPT
SCHEMBL2487346 0.79 P2RX7 (0.42) BRD4CREBBPNAMPT
SCHEMBL10095067 0.77 BRD4 (0.67) CKS1BSKP1SKP2MAPK1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
EP-2379551-A1 SUBSTITUTED PYRAZOLO [3, 4-B]PYRIDINE COMPOUNDS ArQule, Inc. (US) 2011-10-26 EP disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 CKS1B 710/4885SKP1 2954/4885SKP2 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.